当t-PSA处于低水平时游离PSA百分比在前列腺癌鉴别诊断中的价值探讨Value discuss of free PSA percent for differential diagnosis of prostate cancer when t-PSA low
王冠华
摘要(Abstract):
目的探讨游离前列腺特异性抗原百分比在前列腺癌(PCa)诊断中的价值。方法检测50例正常人、46例良性前列腺增生(BPH)患者和32例PCa患者的血清t-PSA和f-PSA,其中BPH和PCa患者t-PSA均在4.0~10.0μg/L,并求得f-PSA百分比,然后进行统计分析。结果疾病组t-PSA水平((6.47±1.66,7.05±2.61)μg/L)明显高于正常对照组((1.02±0.91)μg/L)(P<0.01),而PCa组((7.05±2.61)μg/L)与BPH组((6.47±1.66)μg/L)无显著性差异(P>0.05);BPH组f-PSA百分比((21±11)%)明显高于PCa组((12±9)%),两者有非常显著性差异(P<0.01)。把f-PSA百分比值划分成8个区间,分别为≤8%、≤10%、≤12%、≤14%、≤16%、≤18%、≤20%、≤22%。当f-PSA百分比12%作为诊断PCa的临界值时,诊断的敏感性、特异性、阳性预测值、阴性预测值及正确诊断指数分别为75.0%,73.9%,66.7%,81.0%和48.9%。总的来说,12%的诊断标准最合适。结论f-PSA百分比结合临床表现和影像学检查及其他诊断指标,可显著提高PSA对PCa诊断的特异性,为低水平血清t-PSA的PCa的鉴别诊断提供新的思路。
关键词(KeyWords): 前列腺特异性抗原;游离前列腺特异性抗原百分比;前列腺肿瘤;良性前列腺增生
基金项目(Foundation):
作者(Author): 王冠华
参考文献(References):
- [1]Caplan A,Kratz A.Prostate-specific antigen and the early diagnosisof prostate cancer[J].Am J Clin Pathol,2002,117(Suppl):S104-108
- [2]Thakur V,Singh PP,Talwar M,et al.Utility of free/total prostatespecific antigen(f/t PSA)ratio in diagnosis of prostate carcinoma[J].Dis Markers,2003-2004,19(6):287-292
- [3]Finne P,Auvinen A,Aro J,et al.Estimation of prostate cancer riskon the basis of total and free prostate-specific antigen,prostate vol-ume and digital rectal examination[J].Eur Urol,2002,41(6):619
- [4]Hammerer P,Huland H.Systematic sextant biopsies in 651 patientsreferred for prostate evaluation[J].J Urol,1994,151:99-102
- [5]Tanguay S,Begin LR,Elhilali MM,et al.Comparative evaluationof total PSA,free/total PSA,and complexed PSA in prostate can-cer detection[J].Urology,2002,59(2):261-265
- [6]Stephen Lieberman.Can percent free prostate-specific antigen re-duce the need for prostate biopsy?[J].Eff Clin Pract,1999,2(6):266-271
文章评论(Comment):
|
||||||||||||||||||
|
||||||||||||||||||